We report herein on the assessment of GBM-specific expression of sig1R by a combination of in vitro and in vivo approaches using mice bearing intracranial U87-MG tumours as a preclinical orthotopic model of human GBM and the sig1R-specific radioligand (S)-(−)-[18F]fluspidine. Here, SIGMAR1 is linked to neoplasm.